|
Market Closed -
Nasdaq
16:00:00 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 0.7420 USD | -10.20% |
|
-25.79% | -68.15% |
| 11-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 11-10 | Spero Therapeutics, Inc. Announces Board and Committee Changes | CI |
Chart calendar Spero Therapeutics, Inc.
Upcoming events on Spero Therapeutics, Inc.
No events available
Past events on Spero Therapeutics, Inc.
| 2026-08-12 | Earnings presentation | 17:00 |
| 2026-08-12 | Earnings release - Q2 2026 | |
| 2026-06-23 | Annual General Meeting | 09:00 |
| 2026-06-23 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-05-13 | Earnings release - Q1 2026 | |
| 2026-03-26 | Earnings release - Q4 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 104 48,9 112.29% | 48,0 39,0 23.12% | 0,00 0,00 - | 0,28 | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 21,5 -34,5 162.35% | -73,4 -69,1 -6.22% | 0,00 0,00 - | -67,8 | -50,8 | -61,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 25,4 -25,9 197.95% | -68,6 -66,7 -2.77% | 0,00 0,00 - | -71,5 | -54,3 | -65,4 |
|
Net income Million USD | Released Forecast Spread | 22,8 -33,7 167.75% | -68,6 -64,8 -5.79% | 0,00 0,00 - | -71,5 | -54,3 | -65,4 |
|
EPS USD | Released Forecast Spread | 0,43 -0,69 162.55% | -1,27 -0,92 -38.04% | 0,15 -0,10 250% | -1,23 | -0,40 | -1,03 |
| Announcement Date | 13/03/24 | 27/03/25 | 26/03/26 | - |
Quarterly results
| Fiscal Period | September | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,87 0,00 - | 14,2 0,00 - | 5,44 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,6 -30,5 52.28% | -2,44 -21,2 88.47% | -7,92 -14,4 45.03% | -41,9 -9,50 -341.19% | -8,45 | -10,5 | -11,0 | -12,5 | -12,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -44,3 -8,40 -427.12% | -10,5 | -13,1 | -13,6 | -15,1 | -15,1 | |||
|
Net income Million USD | Released Forecast Spread | -13,9 -30,5 54.54% | -1,70 -21,2 91.98% | -7,38 -14,4 48.74% | -44,3 -8,40 -427.12% | -10,5 | -13,1 | -13,6 | -15,1 | -15,1 |
|
EPS USD | Released Forecast Spread | -0,25 -0,55 54.55% | -0,03 -0,38 92.11% | -0,13 -0,25 48% | -0,76 -0,14 -442.86% | -0,18 | -0,20 | -0,22 | -0,25 | -0,26 |
| Announcement Date | 13/05/25 | 12/08/25 | 13/11/25 | 12/11/26 | - | - | - | - | - |
| 2026-11-23 | Extraordinary General Meeting | ||
| 2026-11-30 | Information meeting | 08:00 | |
| 2026-11-30 | Earnings presentation | 03:00 | |
| 2026-12-02 | Extraordinary General Meeting | 01:30 | |
| 2026-12-07 | Extraordinary General Meeting | 22:00 | |
| 2026-12-08 | Information meeting | 03:00 | |
| 2026-12-14 | Annual General Meeting | ||
| 2026-12-15 | Présentation aux Actionnaires / Analystes | 12:00 | |
| 2026-12-15 | Information meeting | 08:30 | |
| 2026-12-16 | Information meeting | 10:30 |
Past sector events for Spero Therapeutics, Inc.
| Today | Sales and Revenue Release - Q3 2026 | P | |
| 2026-11-19 | Information meeting | 08:30 | |
| 2026-11-19 | Earnings presentation | 02:00 | |
| 2026-11-19 | Earnings presentation | 02:00 | |
| 2026-11-18 | Earnings presentation | 21:00 | |
| 2026-11-17 | Information meeting | 07:45 | |
| 2026-11-16 | Earnings release - Q3 2026 | ||
| 2026-11-16 | Earnings presentation | 16:30 | |
| 2026-11-16 | Information meeting | 08:00 | |
| 2026-11-15 | Information meeting | 12:00 |
Quarterly revenue - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
- Calendar Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















